ArticleHaematologica2025

T-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.

Cilia R Pothast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.